search

el-meyer / airship

AIRSHIP - An Interactive R-SHIny apP for visualizing tidy long data
https://el-meyer.github.io/airship/
GNU General Public License v3.0
3 stars 2 forks source link
clinical-trials ggplot2 interactive interactive-visualizations simulation visualization

readme

AIRSHIP - An Interactive R-SHIny apP for data visualization

 

General Information

This app is designed to plot simulation results of clinical trials. Its main feature is allowing users to simultaneously investigate the impact of several simulation input dimensions through dynamic filtering of the simulation results. A more detailed description of the core app can be found in Meyer et al. Please note that the app has evolved since the paper was published. The app is optimized for FACTS - Fixed and Adaptive Clinical Trial Simulator - simulation output files, but can be used with any dataset in .csv format.

Installation and Execution

You can install the latest stable version from GitHub using:

# install.packages("devtools")
devtools::install_github("el-meyer/airship@*release")

and run the app using:

library(airship)
airship()

The development version can be installed using:

# install.packages("devtools")
devtools::install_github("el-meyer/airship")

In some instances, the installation may fail and error with an uninformative "lazy-loading" error. Installing Rtools may solve the problem. This is particularly true when running Windows on a VM on an ARM based machine.

Documentation

Please see the reference manual for more information on the usage of this package. You can also directly jump to the vignette or one of the examples: example1 and example2.

Funding

Elias Laurin Meyer is a salaried employee of Berry Consultants and was previously a member of the EU-PEARL consortium.

EU-PEARL (EU Patient-cEntric clinicAl tRial pLatforms) project has received funding from the Innovative Medicines Initiative (IMI) 2 Joint Undertaking (JU) under grant agreement No 853966. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA and Children’s Tumor Foundation, Global Alliance for TB Drug Development non-profit organization, Springworks Therapeutics Inc. This publication reflects the authors’ views. Neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.